Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases

Clinical and Experimental Rheumatology

Volumn 26, Issue 1, 2008, Pages 121-124

  Koga, Tomohiro ^a   Migita, Kiyoshi ^a   Miyashita, Taichiro ^a   Maeda, Yumi ^a   Nakamura, Minoru ^a   Abiru, Seigo ^a   Myoji, Masashi ^a   Komori, Atsumasa ^a   Yano, Koji ^a   Yatsuhashi, Hiroshi ^a   Eguchi, Katsumi ^b   Ishibashi, Hiromi ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti cyclic citrullinated peptide antibodies; Autoimmune hepatitis; HCV infection; Primary biliary cirrhosis; Rheumatoid factor

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; SMOOTH MUSCLE ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; PEPTIDES, CYCLIC; RHEUMATOID FACTOR;

EID: 40749161945     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. LEE YH, JI JD, YEON JE, BYUN KS, LEE CH, SONG GG: Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann Rheum Dis 1998; 57: 728-31.
2. LOVY MR, STARKEBAUM G, UBEROI S: Hepatitis C infection presenting with rheumatic manifestations: A mimic of rheumatoid arthritis. J Rheumatol 1996; 23: 979-83.
3. SIEGEL JL, LUTHRA H, DONLINGER J, ANGULO P, LINDOR K: Association of primary biliary cirrhosis and rheumatoid arthritis. J Clin Rheumatol 2003; 9: 340-3.
4. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
5. CLIFFORD BD, DONAHUE D, SMITH L et al.: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-9.
6. SCHELLEKENS GA, DE JONG BA, VAN DEN HOOGEN FH, VAN DE PUTTE LB, VAN VENROOIJ WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
7. SCHELLEKENS GA, VISSER H, DE JONG BA et al.: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
8. LEE DM, SCHUR PH: Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003; 62: 870-4.
9. KROOT EJ, DE JONG BA, VAN LEEUWEN MA et al.: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000; 43: 1831-5.
10. SAUERLAND U, BECKER H, SEIDEL M et al.: Clinical utility of the anti-CCP assay: Experiences with 700 patients. Ann NY Acad Sci 2005; 1050: 314-8.
11. FUSCONI M, VANNINI A, DALL'AGLIO AC et al.: Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis. Aliment Pharmacol Ther 2005; 22: 951-5.
12. ALVAREZ F, BERG PA, BIANCHI FB et al.: International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
13. RIEDEMANN JP, MUNOZ S, KAVANAUGH A: The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis - a systematic review. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S69-76.
14. WENER MH, HUTCHINSON K, MORISHIMA C, GRETCH DR: Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum 2004; 50: 2305-8.
15. BOMBARDIERI M, ALESSANDRI C, LABBADIA G et al.: Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004; 6: R137-41.
16. VANNINI A, CHEUNG K, FUSCONI M et al.: Anti-CCP2 positivity in non-rheumatoid arthritis disease samples: Citrulline-dependent or not? Ann Rheum Dis 2007; 66: 511-6.
17. ONJI M, NONAKA T, HORIIKE N, MORIWAKI H, MUTO Y, OHTA Y: Present status of autoimmune hepatitis in Japan. Gastroenterol Jpn 1993; 28 (Suppl. 4): 134-8.
18. IRIGOYEN P, LEE AT, WENER MB et al.: Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005; 52: 3813-8.
19. MONTANO-LOZA A, CZAJA AJ, CARPENTER HA et al.: Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis. Autoimmunity 2006; 39: 341-8.